Erythromycin Ethyl Side Effects
Side effects of Erythromycin Ethyl (E-MYCIN 200 erythromycin 200mg/5mL (as ethylsuccinate) powder for oral liquid bottle) that impact work capacity, driving, and recovery for claims professionals, support workers, and care managers. Also known as E-MYCIN 200 erythromycin 200mg/5mL (as ethylsuccinate) powder for oral liquid bottle, E-MYCIN 400 erythromycin 400mg/5mL (as ethylsuccinate) powder for oral liquid bottle, E-MYCIN erythromycin 400mg (as ethylsuccinate) tablet bottle.
Erythromycin Ethyl (E-MYCIN 200 erythromycin 200mg/5mL (as ethylsuccinate) powder for oral liquid bottle) is classified as Low risk by AllMeds. For claims professionals, the side effects of Erythromycin Ethyl can impact work capacity, driving fitness, and recovery timelines.
Key Takeaways
- Risk level: Low (1 points)
- Cardiac risk: QTc prolongation, requires monitoring
- Duration limit: 14 days recommended maximum
- Claims action: Assess work capacity impact, check for dangerous interactions, review duration against guidelines
Side Effects That Affect Work Capacity
These side effects of Erythromycin Ethyl can directly impact a claimant's ability to work, drive, and perform daily activities:
- Nausea and constipation
Work capacity certificates should reflect any medication-related restrictions. For safety-sensitive roles (driving, operating machinery, working at heights), these effects may require modified duties or temporary stand-down.
Serious Safety Concerns
These side effects require clinical monitoring and may affect claim management decisions:
- QTc prolongation (abnormal heart rhythm)
- Risk of cardiac arrhythmia, especially with other QTc-prolonging drugs
Dependency and Withdrawal
Erythromycin Ethyl carries a risk of physical dependence with regular use. This is a common complicating factor in injury claims:
- Physical dependence with regular use
- Tolerance requiring dose escalation
- Withdrawal symptoms on cessation
Flags for Claims Professionals
- QTc prolongation risk requires cardiac monitoring and drug interaction review
- Opioid dependency risk increases with duration beyond guidelines
- Recommended maximum duration: 14 days
Need to assess this medication across your caseload?
Run a full risk assessment to check Erythromycin Ethyl side effects, interactions, and compliance across the full medication list.
AllMeds gives you instant risk assessments, compliance checks, and automated letters for every medication on a claim.
No credit card required. No signup for your first 2 questions.
Related Resources
Medical Disclaimer: This content is for informational purposes for claims professionals and care workers. It is not medical advice. Always consult a qualified healthcare professional for clinical decisions. Drug information is sourced from TGA, FDA, MHRA, PBS, NICE, and CDC databases and may not reflect the latest updates. AllMeds does not replace clinical judgement.